Board Director and Former Founding CEO @ (September 2018 - Present)
Board Member @ (April 2021 - April 2023)
Vice President, Translational Sciences @ (October 2017 - April 2023)
Board Observer @ (September 2020 - December 2022)
Board Member and Former Founding Chief Executive Officer @ (September 2018 - Present)
Vice President, Translational Sciences @ (October 2017 - March 2023)
Chief Financial Officer @ (July 2016 - September 2017)
Executive Roundtable @ (January 2014 - July 2016)
Vice President of Finance @ (September 2012 - July 2016)
Deputy Director Fp and A, Global Health @ (January 2006 - September 2012)
Senior Manager, Fp and A @ (February 2002 - November 2005)
Senior Consultant @ (September 1999 - September 2001)
Rob Lin Education
Harvard University
(Philosophy)
2000
Harvard University
Doctor Of Philosophy (Genetics)
1992-2000
Stanford University
Master Of Science (Chemical Engineering)
1988-1992
Stanford University
Bachelor Of Science
1988-1992
Rob Lin Skills
Infectious Diseases
Strategic Planning
Biotechnology
Vaccines
Lifesciences
Global Health
Clinical Trials
Data Analysis
Cross-functional Team Leadership
Oncology
Pharmaceutical Industry
Epidemiology
Financial Modeling
Project Management
Public Health
Strategy
Clinical Research
Health Economics
Healthcare
Nonprofits
Cancer
Clinical Development
Grant Writing
Health Policy
Leadership
Life Sciences
Management
Start-ups
Positioning
Consulting
Market
Screening
Windows
England
Finance
Rationale
Streams
Strategic Analytics
Value Creation
Thesis
Elasticity
Construction
Temporary Placement
Cross Functional Team Leadership
Legal
Monte Carlo Simulation
Nih
Advantages
Benchmarking
Long Range Planning
Design
Funding
Sensitivity
Data Mining
Medical Affairs
Boston
Early Stage
B2B
Factor
Trees
Valuation
Linear
Structured Analysis
Portfolio Management
Rock Climbing
Inflammation
LIN
In Licensing
World Travel
Cost Drivers
Acquisitions
Training
Transcription
Private Equity
Customer Acquisition
Start Up Ventures
Commercial Real Estate
R&D
Board of Directors
Partnerships
Hardware
Analysis
Jordan
Constraints
Assumptions
NPV
Corporate Finance
Resource Development
IT
Softball
Market Planning
Chemical Engineering
Business Development
Negotiation
Sheet
Scientific
Operations
Values
Out Licensing
Marketing
Value Propositions
Pipelines
Optical Communications
Genetics
Deal Flow
Short Term
Pricing
Vienna
Chartered Financial Analyst
Internal Audit
Solid Analytical
Biology
Google Groups
Start Ups
Microsoft Exchange
Investments
Software
Web Site Design
Business Planning
Cash
Manufacturing
Biologics
Cardiac
Financial Transactions
Due Diligence
Technical Issues
Mergers and Acquisitions
Evaluation
Coordinated
Apache Ivy
Rob Lin Summary
Rob Lin, based in Pittsburgh, PA, US, is currently a Chief Executive Officer at Avista Therapeutics. Rob Lin brings experience from previous roles at BlueSphere Bio, Code Biotherapeutics, UPMC Enterprises and SparingVision. Rob Lin holds a Harvard University. With a robust skill set that includes Infectious Diseases, Strategic Planning, Biotechnology, Vaccines, Lifesciences and more. Rob Lin has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Rob Lin?
Find contact details for 700 million professionals.